KRT19 and neoplasm: Thus, our data suggest that KRT19 might function as a promising tumor suppressor gene for targeting highly aggressive patient-derived ALDH1high, CXCR4high, and CD133high breast cancer stem cell-like cells, and could enable cancer cell reprogramming to less aggressive and more drug-sensitive cells.